Bloomage Biotechnology Corp (688363.SS) Stock Price

Bloomage Biotechnology Corp. Ltd. generates revenue through the production and sale of hyaluronic acid, sodium hyaluronate bulk drugs, and medical supplements via fermentation. The company's product portfolio includes raw material products featuring bioactive compounds centered on hyaluronic acid, used across pharmaceuticals, medical devices, cosmetics, functional food, and general food sectors. Medical end products target medical beauty and medicine segments with offerings like ophthalmic viscoelastics, medical lubricants, soft tissue fillers, and medical skin protectors. Functional skin care products consist of lotions, creams, facial masks, and hand masks, while functional foods include hyaluronic acid water and hyaluronic acid food. The company serves pharmaceutical manufacturers, cosmetic brands, and food producers seeking hyaluronic acid-based solutions. The firm's raw material products form the core of its business, supplying bioactive ingredients for diverse industries. Medical end products cater to healthcare providers and clinics specializing in aesthetic procedures and medical treatments. Functional skin care products are sold to cosmetic retailers and e-commerce platforms, while functional foods target health-conscious consumers through food and beverage companies. All products are distributed through established channels without mentioning specific partners or distributors. Bloomage Biotechnology's revenue streams are directly tied to the demand for hyaluronic acid across multiple applications. The company's fermentation-based production method enables cost-effective manufacturing of high-quality raw materials and end products. Its product range spans from bulk pharmaceutical ingredients to consumer-facing items, allowing it to capture value across the entire supply chain from ingredient suppliers to final consumers.